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Background
HIV-infected patients have an increased risk of cardio-
vascular disease. Measurement of carotid artery intima-
media-thickness (c-IMT) with colour-doppler-ultrasono-
graphy is a well-accepted, non-invasive method to assess
carotid atherosclerosis.
Purpose of the study
To investigate whether HCV infection could be involved
in the development of carotid atherosclerosis beside the
well-known risk factors.
Patients and methods
In this cohort study, 322 consecutive HIV+ subjects
were identified and enrolled between May 2009 and
May 2010. A total of 153 patients were HIV/HCV co-
infected, whereas 169 were HIV+ mono-infected; 237
patients were treated with highly active antiretroviral
therapy (HAART), and 85 subjects were HAART-naïve.
All patients underwent at least one c-IMT measurement
by the same examiner; an IMT of >0.9 mm was consid-
ered pathological.
Results
Overall, 112/322 (35%) patients showed c-IMT >0.9.
Table 1 shows the correlation between c-IMT and the
following risk factors: age, cigarette smoking, intrave-
nous drug use, CD4 cell count <200/mmc, CDC stage C
of HIV infection, PI-based regimens and HCV co-infec-
tion. A significant statistical association between all con-
sidered factors and increased c-IMT was found. In
particular, HCV co-infection showed a greater associa-
tion in addition to older age, dyslipidemia, stage C of
HIV infection.
Conclusions
In this cohort, several risk factors seem contribute to
inflammatory damage and c-IMT development. Among
them, HCV co-infection has been identified as a major
determinant of carotid atherosclerosis. If the role of
HCV infection will be confirmed in further studies,
HIV-HCV co-infected patients should be strictly moni-
tored for the vascular status.
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n. 210 % n. 112 % p
age >40 years 121 57.6% 105 93.8% <0.0001
cigarette smoking 42 20% 70 63% 0.03
IVDU 79 37.6% 56 50% 0.03
Cholesterolemia >200
mg/dL
50 23.8% 51 45.5% 0.0006
Triglyceridemia >170 mg/
dL
58 27.6% 52 46.4% 0.0006
CDC Stage C 69 38.9% 68 60.7% <0.0001
HAART - PI exposure 56 40.9% 81 59.1% 0.001
CD4 cell count <200/
mmc
36 17.1% 36 32.1% 0.002
HCV co-infection 85 40.5% 68 60.7% 0.0005
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